Use of Antimicrobial Copper Shown to Reduce Hospital Pathogens

July 1, 2011

The early results from a comprehensive multi-site clinical trial have demonstrated that using antimicrobial copper on surfaces of intensive care unit rooms resulted in a reduction of hospital-acquired infection bacteria by 97 percent.

The study, vialis 40mg which was funded by the U.S. Department of Defense, sales “was designed to determine the efficacy of antimicrobial copper in reducing the level of pathogens in hospitals rooms, and whether such a reduction would translate into a lower risk of infection.”

The researchers of three hospitals were involved in the trial: Memorial Sloan Kettering Cancer Center in New York, the Medical University of South Carolina, and the Ralph H. Johnson VA Medical Center of South Carolina.

The research involved replacing commonly touched items with antimicrobial copper. Typical items were bed rails, overbed tray tables, nurse call buttons, and IV poles.

The demonstrated reduction in rate is the same as that achieved by terminal cleaning–cleaning conducted after a patient vacates a room.

Dr. Michael Schmidt, Professor and Vice Chairman of Microbiology and Immunology at MUSC, who presented the results at ICPIC, said, “Bacteria present on ICU room surfaces are probably responsible for up to 80 percent of patient infections, demonstrating how critical it is to keep hospitals clean. The copper objects used in the clinical trial lowered microbial levels and supplemented cleaning protocols.”

Source: Press Release, New Technology Kills bacteria That Cause Hospital Infections. PRNewswire, July 1, 2011.

Leave a Comment

Previous post:

Next post: